Department of Global Health & Social Medicine, King's College London, London, UK.
Health Econ Policy Law. 2022 Oct;17(4):444-470. doi: 10.1017/S1744133122000032. Epub 2022 Mar 16.
The National Institute for Health and Care Excellence (NICE) is the UK's primary health care priority-setter, responsible for advising the National Health Service on its adoption of health technologies. The normative basis for NICE's advice has long been the subject of public and academic interest, but the existing literature does not include any comprehensive summary of the factors observed to have substantively shaped NICE's recommendations. The current review addresses this gap by bringing together 29 studies that have explored NICE decision-making from different disciplinary perspectives, using a range of quantitative and qualitative methods. It finds that although cost-effectiveness has historically played a central role in NICE decision-making, 10 other factors (uncertainty, budget impact, clinical need, innovation, rarity, age, cause of disease, wider societal impacts, stakeholder influence and process factors) are also demonstrably influential and interact with one another in ways that are not well understood. The review also highlights an over-representation in the literature of appraisals conducted prior to 2009, according to methods that have since been superseded. It suggests that this may present a misleading view of the importance of allocative efficiency to NICE's current approach and illustrates the need for further up-to-date research into the normative grounds for NICE's decisions.
英国国家卫生与保健优化研究所(NICE)是英国首要的医疗保健优先级制定者,负责就国家医疗服务体系对医疗技术的采用向其提供建议。NICE 建议的规范基础一直是公众和学术界关注的焦点,但现有文献中没有任何关于观察到的实质性影响 NICE 建议的因素的综合总结。本综述通过汇集 29 项研究来填补这一空白,这些研究从不同的学科角度探讨了 NICE 的决策过程,采用了多种定量和定性方法。研究发现,尽管成本效益在 NICE 的决策中一直发挥着核心作用,但其他 10 个因素(不确定性、预算影响、临床需求、创新、罕见性、年龄、疾病原因、更广泛的社会影响、利益相关者的影响和流程因素)也具有明显的影响力,并且以尚未被很好理解的方式相互作用。该综述还强调了文献中存在的一个问题,即根据已经过时的方法,2009 年之前进行的评估占比过高。这可能会对 NICE 当前方法中分配效率的重要性产生误导性的看法,并说明了需要进一步开展关于 NICE 决策规范基础的最新研究。